Head, Field Medical Affairs — Rare Diseases

Regeneron Pharmaceuticals; Paderno Dugnano; In loco; EUR 110.000 - 125.000; Tempo pieno

Descrizione del lavoro

A global biopharmaceutical company is seeking a Senior Medical Science Liaison to connect science with real-world impact. The ideal candidate will have 12+ years of relevant experience, an advanced clinical degree, and be comfortable navigating complex healthcare systems. This role involves leading scientific discussions, evaluating health assessments, and supporting clinical trials. A strong emphasis on building relationships and advancing rare disease innovation is required. Comprehensive benefits offered.

Servizi

Health and wellness programs

Fitness centers

401(k) company match

Annual bonuses

Paid time off

Competenze

• At least 12 years of experience in clinical practice, managed care, or the pharmaceutical industry.
• Minimum of two years in Medical Affairs.
• Experience as a Medical Science Liaison or in a similar role is a plus.
• Fluent in English; proficiency in French, Spanish, Italian, or German is encouraged.

Mansioni

• Lead scientific discussions with healthcare professionals.
• Evaluate health technology assessments and market access strategies.
• Respond accurately to medical inquiries.
• Collaborate across functions to support speaker training.
• Share field insights for medical planning.

Conoscenze

Strategic problem solving

Building trusted relationships

Translating clinical data

Navigating complex environments

Formazione

Advanced clinical or scientific degree (MD, DO, PharmD, or PhD)

Descrizione del lavoro

A global biopharmaceutical company is seeking a Senior Medical Science Liaison to connect science with real-world impact. The ideal candidate will have 12+ years of relevant experience, an advanced clinical degree, and be comfortable navigating complex healthcare systems. This role involves leading scientific discussions, evaluating health assessments, and supporting clinical trials. A strong emphasis on building relationships and advancing rare disease innovation is required. Comprehensive benefits offered.